PDPR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.721900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.765400E-01
Normal-vs-Stage2
6.766300E-02
Normal-vs-Stage3
1.747200E-01
Normal-vs-Stage4
7.519200E-01
Stage1-vs-Stage2
5.692600E-01
Stage1-vs-Stage3
1.175200E-01
Stage1-vs-Stage4
1.961040E-01
Stage2-vs-Stage3
1.437010E-01
Stage2-vs-Stage4
2.396200E-01
Stage3-vs-Stage4
1.227990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.524300E-02
Normal-vs-AfricanAmerican
4.160200E-01
Normal-vs-Asian
1.526410E-02
Caucasian-vs-AfricanAmerican
4.020600E-01
Caucasian-vs-Asian
5.438200E-02
AfricanAmerican-vs-Asian
4.253700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.921600E-02
Normal-vs-Female
9.676100E-02
Male-vs-Female
5.561200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.273600E-01
Normal-vs-Age(41-60Yrs)
1.667810E-01
Normal-vs-Age(61-80Yrs)
4.737900E-02
Normal-vs-Age(81-100Yrs)
8.650400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.791000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.232600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.794200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.065570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.251240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.936800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.474100E-02
Normal-vs-Daily Drinker
4.700300E-02
Normal-vs-Weekly Drinker
2.883900E-02
Normal-vs-Occasional Drinker
1.537610E-01
Normal-vs-Social Drinker
4.799600E-01
Non Drinker-vs-Daily Drinker
9.251200E-01
Non Drinker-vs-Weekly Drinker
9.007400E-01
Non Drinker-vs-Occasional Drinker
2.964000E-01
Non Drinker-vs-Social Drinker
3.471700E-02
Daily Drinker-vs-Weekly Drinker
8.414200E-01
Daily Drinker-vs-Occasional Drinker
3.032600E-01
Daily Drinker-vs-Social Drinker
4.785900E-02
Weekly Drinker-vs-Occasional Drinker
3.996200E-01
Weekly Drinker-vs-Social Drinker
7.514000E-02
Occasional Drinker-vs-Social Drinker
2.970800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.609250E-01
Normal-vs-Grade 2
4.724100E-02
Normal-vs-Grade 3
8.606300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.926020E-01
Grade 1-vs-Grade 3
1.861590E-02
Grade 1-vs-Grade 4
1.609250E-01
Grade 2-vs-Grade 3
4.948500E-02
Grade 2-vs-Grade 4
4.724100E-02
Grade 3-vs-Grade 4
8.606300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.011500E-02
Normal-vs-NonDiabetic
3.105900E-02
Diabetic-vs-NonDiabetic
7.862600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.281200E-01
Normal-vs-NoPancreatitis
2.450300E-02
Pancreatitis-vs-NoPancreatitis
1.039980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.269800E-02
Normal-vs-N1
8.288500E-02
N0-vs-N1
3.527000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.170200E-01
Normal-vs-TP53-NonMutant
1.442570E-01
TP53-Mutant-vs-TP53-NonMutant
2.892800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
